When Roche got Herceptin onto China’s national insurance program, it didn’t expect demand to surge so quickly, overwhelming its production capacity there. Now, to cope with a nationwide shortage, it’s shifting to a different manufacturing site to amp up supplies of the cancer therapy.
Roche applied to change Herceptin's existing production site for China to a high...
The treatment could relieve haemophilia B patients from factor IX replacement drugs
UniQure has enrolled the first patient in its registration trial of haemophilia B gene therapy candidate AMT-061 as it tries to keep ahead of a rival project from Spark Therapeutics/Pfizer.
The subject is the first out of around 50 subjects that will be recruited into the open-label HOPE-B trial of AMT-061, an a...
Neural Analytics, the Los Angeles based company that won FDA clearance a couple of years ago for its Lucid M1 Transcranial Doppler Ultrasound System, now won another clearance, this time for its NeuralBot robotic ultrasound positioner. The two devices work together and when united will be called the Lucid Robotic System.
The NeuralBot automatically positions the ultrasound probe,...
Among susceptible individuals, statins — which are a common cholesterol-lowering medication — could increase the risk of type 2 diabetes by 30 percent. These new findings are sure to reignite debate. The relationship between statins and diabetes is investigated in a new study.
Statins lower cholesterol by reducing its production in the liver. They do this...